 And so I wonder how much of a challenge that may be as we go forward thinking about what to do here. Because, you know, if the guideline is for colorectal cancer, for example, screen 45 and after, but we're looking at people in their 30s or possibly even 20s, it doesn't seem to me that an insurance company would find that to be adequate evidence to approve screenings when maybe that's what we need.